The adenosine pathway in immuno-oncology

B Allard, D Allard, L Buisseret, J Stagg - Nature Reviews Clinical …, 2020 - nature.com
Cancer immunotherapy based on immune-checkpoint inhibition or adoptive cell therapy has
revolutionized cancer care. Nevertheless, a large proportion of patients do not benefit from …

Environmental triggers in IBD: a review of progress and evidence

AN Ananthakrishnan, CN Bernstein… - Nature reviews …, 2018 - nature.com
A number of environmental factors have been associated with the development of IBD.
Alteration of the gut microbiota, or dysbiosis, is closely linked to initiation or progression of …

Negative feedback control of neuronal activity by microglia

A Badimon, HJ Strasburger, P Ayata, X Chen, A Nair… - Nature, 2020 - nature.com
Microglia, the brain's resident macrophages, help to regulate brain function by removing
dying neurons, pruning non-functional synapses, and producing ligands that support …

Características clínicas y factores asociados a mortalidad en pacientes adultos hospitalizados por COVID-19 en un hospital público de Lima, Perú.

F Mejía, C Medina, E Cornejo, E Morello… - SciELO …, 2020 - researchonline.lshtm.ac.uk
La pandemia por COVID-19 ha representado un duro golpe al sistema sanitario peruano, y
las estrategias implementadas para el control de la epidemia han sido insuficientes en el …

The ectonucleotidases CD 39 and CD 73: novel checkpoint inhibitor targets

B Allard, MS Longhi, SC Robson… - Immunological …, 2017 - Wiley Online Library
Cancers are able to grow by subverting immune suppressive pathways, to prevent the
malignant cells as being recognized as dangerous or foreign. This mechanism prevents the …

CD39 and CD73 in immunity and inflammation

L Antonioli, P Pacher, ES Vizi, G Haskó - Trends in molecular medicine, 2013 - cell.com
The enzymatic activities of CD39 and CD73 play strategic roles in calibrating the duration,
magnitude, and chemical nature of purinergic signals delivered to immune cells through the …

Targeting hypoxia-inducible factors: therapeutic opportunities and challenges

X Yuan, W Ruan, B Bobrow, P Carmeliet… - Nature Reviews Drug …, 2024 - nature.com
Hypoxia-inducible factors (HIFs) are highly conserved transcription factors that are crucial for
adaptation of metazoans to limited oxygen availability. Recently, HIF activation and …

Co-inhibition of CD73 and A2AR adenosine signaling improves anti-tumor immune responses

A Young, SF Ngiow, DS Barkauskas, E Sult, C Hay… - Cancer cell, 2016 - cell.com
Preclinical studies targeting the adenosinergic pathway have gained much attention for their
clinical potential in overcoming tumor-induced immunosuppression. Here, we have …

Ischemia and reperfusion—from mechanism to translation

HK Eltzschig, T Eckle - Nature medicine, 2011 - nature.com
Ischemia and reperfusion–elicited tissue injury contributes to morbidity and mortality in a
wide range of pathologies, including myocardial infarction, ischemic stroke, acute kidney …

Adenosine receptors as drug targets—what are the challenges?

JF Chen, HK Eltzschig, BB Fredholm - Nature reviews Drug discovery, 2013 - nature.com
Adenosine signalling has long been a target for drug development, with adenosine itself or
its derivatives being used clinically since the 1940s. In addition, methylxanthines such as …